FDA Inspection 1253117 — Laboratorio Italiano Biochimico Farmaceutico Lisapharma SPA
The FDA completed an inspection of Laboratorio Italiano Biochimico Farmaceutico Lisapharma SPA on Sep 26, 2023 in Erba. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 26, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Erba (Italy)